Author

M. F. Segura

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:drug response / drug discovery· 1 Assay:whole-genome sequencing· 1

Frequent Co-Authors

J. Roma· 2 shared J. Sanchez de Toledo· 2 shared L. Moreno· 2 shared S. Gallego· 2 shared A. Magdaleno· 1 shared A. Molero-Valenzuela· 1 shared A. Soriano· 1 shared C. Jimenez· 1 shared

Activity by Year

2022-2022 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 40 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

J. Roma

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologybioRxivNov 16, 2022

Analysis of cancer genomic amplifications identifies druggable collateral dependencies within the amplicon

G. Pons, G. Gallo-Oller, N. Navarro…·J. Roma

The paper identifies druggable collateral dependencies in cancer genomic amplifications using CRISPR/Cas9 screens and integrates gene dependency with druggability and subcellular location data.

DOI 10.3390/cancers15061636

humanwhole-genome sequencing

𝕏 PostBluesky

Cancer BiologyMolecular CancerPeer-reviewedSep 3, 2022

Structural disruption of BAF chromatin remodeller impairs neuroblastoma metastasis by reverting an invasiveness epigenomic program

C. Jimenez, R. Antonelli, M. Nadal-Ribelles…·M. F. Segura

This study shows that disrupting the BAF chromatin remodeller in neuroblastoma cells reduces metastasis by repressing an invasiveness-related epigenomic program.

DOI 10.1186/s12943-022-01643-4

humanbulk RNA-seq

𝕏 PostBluesky